SCHEMBL22904895

SCHEMBL22904895

Cn1c(-c2c(C(=O)O)sc3cccc(Cl)c23)nc2ccc(C(N)=O)cc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK2 O96017 1/20 0.48
▸ MAPK1 P28482 3/20 0.43
▸ MCL1 Q07820 2/20 0.43
▸ F2 P00734 1/20 0.41
▸ F10 P00742 1/20 0.41
▸ PLG P00747 1/20 0.41
▸ PLAU P00749 1/20 0.41
▸ PRSS1 P07477 1/20 0.41
▸ STING1 Q86WV6 4/20 0.41
▸ VDR P11473 3/20 0.40
▸ NR1H4 Q96RI1 3/20 0.40
▸ BMPR2 Q13873 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ PIK3R2 O00459 1/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ CASP7 P55210 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29443061 1.00 CHEK2 (0.48) CHEK2MAPK1MCL1F2F10
SCHEMBL22904894 0.92 MCL1 (0.43) CHEK2MAPK1MCL1STING1VDR
SCHEMBL29443069 0.92 MCL1 (0.43) CHEK2MAPK1MCL1STING1VDR
SCHEMBL22905022 0.88 KDM4E (0.52) CHEK2MAPK1F2F10PLG
SCHEMBL29693898 0.88 KDM4E (0.52) CHEK2MAPK1F2F10PLG
SCHEMBL29443113 0.88 KDM4E (0.52) CHEK2MAPK1F2F10PLG
SCHEMBL24772449 0.84 JAK2 (0.50) MAPK1MCL1
SCHEMBL24771134 0.82 JAK2 (0.52) MAPK1MCL1STING1
SCHEMBL24771131 0.82 JAK2 (0.52) MAPK1MCL1STING1
SCHEMBL22904893 0.81 KDM4E (0.52) CHEK2MAPK1STING1VDRNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617780-B2 Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting CTXT PTY LTD (AU) 2026-05-05 — — US disclosed
EP-3999184-B1 BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING CTXT PTY LTD (AU) 2023-09-20 — — EP disclosed
EP-3999184-B1 BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING CTXT PTY LTD (AU) 2023-09-20 — — EP disclosed
US-20220380354-A1 BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING CTXT PTY LTD (AU) 2022-12-01 — — US disclosed
CN-114206880-A Benzothiophene, thienopyridine, and thienopyrimidine derivatives for modulation of STING CTXT私人有限公司 2022-03-18 — — CN disclosed
WO-2021009362-A1 BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING CTXT PTY LIMITED (AU) 2021-01-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220380354-A1 BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING STING1, CGAS, HRH2 CHEK2 205/4885MAPK1 2293/4885MCL1 1212/4885
US-12617780-B2 Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting STING1, CGAS, IRF3 CHEK2 101/4885MAPK1 2628/4885MCL1 545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback